Healthcare Sector Stocks
The Healthcare sector has a total of 1064 stocks, with a combined market cap of $8.22 trillion, total revenue of $4.57 trillion and a weighted average PE ratio of 41.73.
Market Cap
8.22T
Revenue
4.57T
Profits
197.1B
PE Ratio
41.73
Profit Margin
4.32%
Dividend Yield
0.43%
1064 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 881.82B | 2.16% | 2,955,528 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 542.95B | 0.60% | 5,556,720 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 364.56B | -0.98% | 4,490,528 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 330.47B | -1.86% | 6,489,024 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 280.46B | -1.21% | 2,459,982 | 60.44B |
| 6 | MRK | Merck & Co., Inc. | 279.46B | 0.04% | 7,910,399 | 65.77B |
| 7 | NVS | Novartis AG | 277.08B | 0.61% | 1,328,707 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 198.53B | 1.08% | 21,291,970 | 50.57B |
| 9 | AMGN | Amgen Inc. | 177.88B | 1.77% | 3,321,412 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 173.46B | 0.90% | 2,046,098 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 165.68B | 0.60% | 6,152,431 | 29.44B |
| 12 | ISRG | Intuitive Surgical, Inc. | 159.86B | -0.21% | 2,952,300 | 10.58B |
| 13 | ABT | Abbott Laboratories | 151.83B | -0.42% | 17,193,417 | 45.13B |
| 14 | PFE | Pfizer Inc. | 150.75B | 0.57% | 57,656,105 | 63.32B |
| 15 | DHR | Danaher Corporation | 123.60B | 0.34% | 3,806,059 | 24.78B |
| 16 | BMY | Bristol-Myers Squibb Company | 116.30B | -0.75% | 11,316,685 | 48.48B |
| 17 | SYK | Stryker Corporation | 113.08B | 1.50% | 3,454,693 | 25.27B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 107.87B | -1.28% | 1,906,344 | 12.22B |
| 19 | SNY | Sanofi | 104.18B | 0.02% | 2,224,195 | 54.60B |
| 20 | CVS | CVS Health Corporation | 103.41B | -1.61% | 7,304,698 | 399.83B |
| 21 | GSK | GSK plc | 100.56B | -1.02% | 3,521,804 | 43.29B |
| 22 | MDT | Medtronic plc | 99.87B | -0.65% | 9,327,189 | 35.48B |
| 23 | MCK | McKesson Corporation | 98.11B | -0.85% | 882,287 | 397.96B |
| 24 | HCA | HCA Healthcare, Inc. | 95.12B | 0.38% | 717,110 | 76.39B |
| 25 | BSX | Boston Scientific Corporation | 83.21B | -1.53% | 12,544,098 | 20.61B |
| 26 | ELV | Elevance Health, Inc. | 80.15B | -0.76% | 1,358,681 | 200.42B |
| 27 | CI | The Cigna Group | 72.92B | -1.32% | 1,840,355 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 71.45B | -0.98% | 642,800 | 14.92B |
| 29 | MDLN | Medline Inc. | 59.54B | 2.56% | 4,331,354 | 28.43B |
| 30 | COR | Cencora, Inc. | 59.51B | 0.74% | 1,622,504 | 325.78B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 52.81B | -0.06% | 2,132,544 | 28.48B |
| 32 | ARGX | argenx SE | 49.39B | -2.02% | 248,165 | 4.24B |
| 33 | EW | Edwards Lifesciences Corporation | 47.80B | -0.50% | 3,288,318 | 6.30B |
| 34 | ZTS | Zoetis Inc. | 47.33B | -0.12% | 3,356,065 | 9.47B |
| 35 | CAH | Cardinal Health, Inc. | 46.14B | -0.03% | 1,363,974 | 250.74B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.71B | -0.03% | 734,512 | 4.45B |
| 37 | TEVA | Teva Pharmaceutical Industries Limited | 41.76B | 1.44% | 6,250,082 | 17.35B |
| 38 | BDX | Becton, Dickinson and Company | 41.05B | -1.46% | 3,533,224 | 21.92B |
| 39 | HLN | Haleon plc | 40.23B | -0.76% | 7,903,743 | 14.85B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.20B | 1.07% | 823,895 | 4.29B |
| 41 | ALC | Alcon Inc. | 36.29B | 1.32% | 1,977,660 | 10.63B |
| 42 | WAT | Waters Corporation | 33.65B | 13.54% | 2,131,047 | 3.77B |
| 43 | A | Agilent Technologies, Inc. | 33.21B | 4.77% | 3,008,255 | 7.07B |
| 44 | ONC | BeOne Medicines AG | 33.06B | 0.12% | 175,754 | 5.34B |
| 45 | RVMD | Revolution Medicines, Inc. | 31.30B | -0.47% | 3,321,768 | - |
| 46 | RMD | ResMed Inc. | 30.15B | -0.74% | 1,849,981 | 5.54B |
| 47 | INSM | Insmed Incorporated | 30.10B | -0.41% | 1,238,325 | 606.42M |
| 48 | RPRX | Royalty Pharma plc | 29.90B | 0.48% | 4,722,958 | 2.38B |
| 49 | IQV | IQVIA Holdings Inc. | 29.61B | 9.62% | 4,177,148 | 16.63B |
| 50 | NTRA | Natera, Inc. | 29.52B | -2.26% | 1,065,764 | 2.31B |
| 51 | HUM | Humana Inc. | 28.76B | 0.66% | 1,183,510 | 137.20B |
| 52 | VEEV | Veeva Systems Inc. | 27.96B | 0.57% | 4,404,849 | 3.20B |
| 53 | BIIB | Biogen Inc. | 27.92B | 1.03% | 586,074 | 9.94B |
| 54 | GEHC | GE HealthCare Technologies Inc. | 27.77B | 0.07% | 7,372,577 | 20.98B |
| 55 | MTD | Mettler-Toledo International Inc. | 26.37B | 3.32% | 113,185 | 4.03B |
| 56 | CNC | Centene Corporation | 26.16B | -1.08% | 5,033,587 | 178.33B |
| 57 | PHG | Koninklijke Philips N.V. | 25.22B | 0.80% | 1,421,524 | 20.94B |
| 58 | UTHR | United Therapeutics Corporation | 25.08B | -1.55% | 582,987 | 3.18B |
| 59 | BNTX | BioNTech SE | 24.15B | -3.88% | 1,512,640 | 3.23B |
| 60 | DXCM | DexCom, Inc. | 22.95B | -0.93% | 5,528,662 | 4.82B |
| 61 | WST | West Pharmaceutical Services, Inc. | 21.90B | 3.26% | 896,962 | 3.22B |
| 62 | DGX | Quest Diagnostics Incorporated | 21.13B | -0.34% | 613,835 | 11.28B |
| 63 | LH | Labcorp Holdings Inc. | 21.09B | 1.63% | 894,936 | 14.14B |
| 64 | ILMN | Illumina, Inc. | 21.04B | -0.22% | 1,236,498 | 4.39B |
| 65 | STE | STERIS plc | 20.89B | 0.34% | 566,825 | 5.83B |
| 66 | ROIV | Roivant Sciences Ltd. | 20.27B | -0.14% | 2,646,031 | 13.31M |
| 67 | INCY | Incyte Corporation | 19.47B | 0.34% | 1,038,437 | 5.36B |
| 68 | MRNA | Moderna, Inc. | 18.53B | -1.25% | 4,834,190 | 2.23B |
| 69 | VTRS | Viatris Inc. | 18.07B | 2.11% | 17,435,970 | 14.30B |
| 70 | GMAB | Genmab A/S | 16.69B | 1.78% | 1,179,949 | 3.72B |
| 71 | THC | Tenet Healthcare Corporation | 16.10B | 0.84% | 1,776,466 | 21.46B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 16.06B | 0.41% | 1,606,914 | 8.41B |
| 73 | ASND | Ascendis Pharma A/S | 13.92B | -1.50% | 446,124 | 845.52M |
| 74 | SMMT | Summit Therapeutics Inc. | 13.61B | 3.30% | 4,486,969 | - |
| 75 | NBIX | Neurocrine Biosciences, Inc. | 13.58B | 0.74% | 1,427,489 | 3.10B |
| 76 | RGC | Regencell Bioscience Holdings Limited | 13.48B | -0.33% | 66,466 | - |
| 77 | BBIO | BridgeBio Pharma, Inc. | 13.47B | -0.30% | 2,119,262 | 502.08M |
| 78 | SNN | Smith & Nephew plc | 13.43B | 1.33% | 1,998,377 | 6.16B |
| 79 | JAZZ | Jazz Pharmaceuticals plc | 13.07B | 2.02% | 1,215,230 | 4.44B |
| 80 | PEN | Penumbra, Inc. | 12.74B | -0.24% | 440,078 | 1.40B |
| 81 | IONS | Ionis Pharmaceuticals, Inc. | 12.44B | -0.27% | 850,248 | 1.06B |
| 82 | MEDP | Medpace Holdings, Inc. | 12.29B | 3.19% | 421,432 | 2.68B |
| 83 | GMED | Globus Medical, Inc. | 12.21B | -0.63% | 1,011,925 | 2.94B |
| 84 | ALGN | Align Technology, Inc. | 12.08B | -1.84% | 751,234 | 4.10B |
| 85 | SOLV | Solventum Corporation | 11.97B | 2.37% | 1,944,110 | 8.26B |
| 86 | COO | The Cooper Companies, Inc. | 11.95B | -0.44% | 2,940,673 | 4.15B |
| 87 | GH | Guardant Health, Inc. | 11.74B | -1.81% | 1,378,580 | 982.02M |
| 88 | PODD | Insulet Corporation | 11.60B | -2.25% | 1,473,990 | 2.71B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.53B | -3.12% | 331,161 | 958.40M |
| 90 | ELAN | Elanco Animal Health Incorporated | 11.48B | 2.13% | 6,295,574 | 4.72B |
| 91 | AXSM | Axsome Therapeutics, Inc. | 11.48B | -0.29% | 1,019,975 | 708.24M |
| 92 | EXEL | Exelixis, Inc. | 11.28B | 0.57% | 3,563,502 | 2.38B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.13B | -0.67% | 1,819,031 | 3.85B |
| 94 | FMS | Fresenius Medical Care AG | 10.93B | -10.86% | 2,654,111 | 22.32B |
| 95 | BTSG | BrightSpring Health Services, Inc. | 10.58B | -3.92% | 4,040,045 | 13.65B |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.49B | -1.91% | 1,257,550 | 1.09B |
| 97 | EHC | Encompass Health Corporation | 10.43B | -1.39% | 1,073,849 | 6.07B |
| 98 | DVA | DaVita Inc. | 10.36B | 1.92% | 1,997,963 | 13.84B |
| 99 | RVTY | Revvity, Inc. | 10.32B | 6.69% | 2,076,230 | 2.90B |
| 100 | BMRN | BioMarin Pharmaceutical Inc. | 10.29B | -4.00% | 3,823,281 | 3.24B |
| 101 | ENSG | The Ensign Group, Inc. | 10.20B | -3.34% | 598,856 | 5.27B |
| 102 | UHS | Universal Health Services, Inc. | 10.09B | -0.40% | 1,097,614 | 17.76B |
| 103 | MOH | Molina Healthcare, Inc. | 10.01B | -1.72% | 1,138,992 | 43.10B |
| 104 | ABVX | ABIVAX Société Anonyme | 9.78B | 5.68% | 1,267,923 | 5.37M |
| 105 | TEM | Tempus AI, Inc. | 9.69B | -3.12% | 5,966,684 | 1.36B |
| 106 | CYTK | Cytokinetics, Incorporated | 9.58B | 16.71% | 18,079,521 | 105.82M |
| 107 | MASI | Masimo Corporation | 9.32B | 0.21% | 1,145,288 | 1.56B |
| 108 | PRAX | Praxis Precision Medicines, Inc. | 9.28B | -1.28% | 514,627 | 7.46M |
| 109 | ICLR | ICON Public Limited Company | 9.26B | 8.35% | 1,594,532 | 8.10B |
| 110 | CRL | Charles River Laboratories International, Inc. | 9.15B | 7.58% | 1,171,581 | 4.02B |
| 111 | TECH | Bio-Techne Corporation | 8.87B | 3.54% | 2,989,127 | 1.22B |
| 112 | BAX | Baxter International Inc. | 8.65B | 0.78% | 7,641,369 | 11.32B |
| 113 | HSIC | Henry Schein, Inc. | 8.53B | 3.26% | 2,453,364 | 13.38B |
| 114 | KRYS | Krystal Biotech, Inc. | 8.39B | -0.83% | 414,582 | 417.30M |
| 115 | PCVX | Vaxcyte, Inc. | 8.03B | -4.87% | 2,169,792 | - |
| 116 | NUVL | Nuvalent, Inc. | 7.98B | -1.12% | 612,539 | - |
| 117 | GKOS | Glaukos Corporation | 7.83B | -1.79% | 888,360 | 551.35M |
| 118 | IBRX | ImmunityBio, Inc. | 7.83B | 2.02% | 9,510,284 | 113.29M |
| 119 | HALO | Halozyme Therapeutics, Inc. | 7.80B | 2.01% | 1,478,959 | 1.40B |
| 120 | ATR | AptarGroup, Inc. | 7.79B | 1.19% | 628,566 | 3.87B |
| 121 | RGEN | Repligen Corporation | 7.08B | 6.26% | 2,088,798 | 763.34M |
| 122 | QGEN | Qiagen N.V. | 7.03B | 0.12% | 1,464,828 | 2.09B |
| 123 | HQY | HealthEquity, Inc. | 6.98B | 0.55% | 501,134 | 1.31B |
| 124 | BIO | Bio-Rad Laboratories, Inc. | 6.88B | -0.29% | 520,692 | 2.59B |
| 125 | CELC | Celcuity Inc. | 6.85B | -2.27% | 1,419,526 | - |
| 126 | KYMR | Kymera Therapeutics, Inc. | 6.80B | -1.05% | 459,709 | 51.48M |
| 127 | GRFS | Grifols, S.A. | 6.60B | 0.49% | 256,937 | 8.83B |
| 128 | MIRM | Mirum Pharmaceuticals, Inc. | 6.45B | 0.02% | 1,176,546 | 521.31M |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 6.33B | -0.31% | 398,044 | 74.06M |
| 130 | COGT | Cogent Biosciences, Inc. | 6.32B | 0.68% | 1,739,527 | - |
| 131 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.32B | 7.86% | 1,899,171 | 217.17M |
| 132 | APGE | Apogee Therapeutics, Inc. | 6.22B | -0.31% | 389,869 | - |
| 133 | CNTA | Centessa Pharmaceuticals plc | 6.14B | -0.08% | 736,556 | 15.00M |
| 134 | SYRE | Spyre Therapeutics, Inc. | 6.13B | 2.72% | 2,010,985 | - |
| 135 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | 0.04% | 6,347,046 | - |
| 136 | BLTE | Belite Bio, Inc | 6.07B | -0.08% | 88,473 | - |
| 137 | ALKS | Alkermes plc | 6.03B | 6.09% | 2,614,335 | 1.56B |
| 138 | HIMS | Hims & Hers Health, Inc. | 6.00B | -3.45% | 15,492,799 | 2.35B |
| 139 | CGON | CG Oncology, Inc. | 5.91B | -0.78% | 743,671 | 4.04M |
| 140 | BRKR | Bruker Corporation | 5.79B | 4.45% | 2,524,070 | 3.44B |
| 141 | BLCO | Bausch + Lomb Corporation | 5.70B | -1.84% | 370,731 | 5.10B |
| 142 | IMVT | Immunovant, Inc. | 5.67B | -0.04% | 1,047,765 | - |
| 143 | CHE | Chemed Corporation | 5.65B | 0.38% | 235,940 | 2.54B |
| 144 | SRRK | Scholar Rock Holding Corporation | 5.62B | 1.41% | 583,550 | - |
| 145 | XENE | Xenon Pharmaceuticals Inc. | 5.58B | 0.54% | 1,230,205 | 7.50M |
| 146 | LNTH | Lantheus Holdings, Inc. | 5.58B | -2.23% | 740,760 | 1.54B |
| 147 | CORT | Corcept Therapeutics Incorporated | 5.51B | -0.52% | 1,176,335 | 769.10M |
| 148 | AVTR | Avantor, Inc. | 5.50B | 0.75% | 5,471,283 | 6.55B |
| 149 | OSCR | Oscar Health, Inc. | 5.40B | -3.39% | 8,756,007 | 11.70B |
| 150 | PTCT | PTC Therapeutics, Inc. | 5.39B | -0.69% | 740,428 | 1.73B |
| 151 | CAI | Caris Life Sciences, Inc. | 5.36B | 1.39% | 1,874,523 | 812.03M |
| 152 | TFX | Teleflex Incorporated | 5.34B | 0.67% | 723,043 | 1.99B |
| 153 | TGTX | TG Therapeutics, Inc. | 5.33B | 1.09% | 2,468,853 | 616.29M |
| 154 | LEGN | Legend Biotech Corporation | 5.27B | 7.58% | 6,591,266 | 1.03B |
| 155 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | - | 2,838,568 | 1.00B |
| 156 | PACS | PACS Group, Inc. | 5.12B | 0.22% | 320,282 | 5.29B |
| 157 | CRSP | CRISPR Therapeutics AG | 5.05B | -2.24% | 3,102,096 | 4.10M |
| 158 | STVN | Stevanato Group S.p.A. | 4.97B | 2.36% | 446,811 | 1.39B |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 4.91B | 1.01% | 343,810 | 2.04M |
| 160 | DOCS | Doximity, Inc. | 4.76B | 3.54% | 2,964,005 | 637.78M |
| 161 | MANE | Veradermics, Incorporated | 4.73B | 9.06% | 1,066,122 | - |
| 162 | LGND | Ligand Pharmaceuticals Incorporated | 4.65B | 1.73% | 105,664 | 268.09M |
| 163 | RDNT | RadNet, Inc. | 4.62B | 1.30% | 976,833 | 2.04B |
| 164 | SHC | Sotera Health Company | 4.37B | -0.39% | 8,117,424 | 1.19B |
| 165 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.36B | -1.53% | 624,939 | 754.05M |
| 166 | AMRX | Amneal Pharmaceuticals, Inc. | 4.28B | 2.29% | 1,283,552 | 3.02B |
| 167 | NVST | Envista Holdings Corporation | 4.27B | 1.47% | 2,089,675 | 2.72B |
| 168 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.27B | -1.21% | 916,839 | 7.70M |
| 169 | TVTX | Travere Therapeutics, Inc. | 4.17B | -0.24% | 3,310,824 | 536.20M |
| 170 | ORKA | Oruka Therapeutics, Inc. | 4.13B | 3.75% | 2,035,949 | - |
| 171 | EWTX | Edgewise Therapeutics, Inc. | 4.09B | 20.86% | 5,050,603 | - |
| 172 | WAY | Waystar Holding Corp. | 3.96B | -1.25% | 2,698,182 | 1.16B |
| 173 | IRTC | iRhythm Holdings, Inc. | 3.88B | -0.90% | 542,084 | 787.85M |
| 174 | HNGE | Hinge Health, Inc. | 3.85B | 1.76% | 5,949,793 | 646.34M |
| 175 | ACAD | ACADIA Pharmaceuticals Inc. | 3.83B | 0.72% | 1,030,988 | 1.07B |
| 176 | ALHC | Alignment Healthcare, Inc. | 3.78B | -4.98% | 6,636,130 | 4.26B |
| 177 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.77B | 6.63% | 2,825,030 | 588.99M |
| 178 | TLX | Telix Pharmaceuticals Limited | 3.76B | -0.99% | 89,957 | 803.79M |
| 179 | BLLN | BillionToOne, Inc. | 3.67B | 10.79% | 1,517,352 | 305.11M |
| 180 | VKTX | Viking Therapeutics, Inc. | 3.64B | -1.42% | 1,974,007 | - |
| 181 | MMSI | Merit Medical Systems, Inc. | 3.61B | -2.53% | 1,010,500 | 1.54B |
| 182 | LQDA | Liquidia Corporation | 3.57B | 4.29% | 1,059,089 | 158.32M |
| 183 | TWST | Twist Bioscience Corporation | 3.53B | 0.91% | 1,637,585 | 409.48M |
| 184 | OGN | Organon & Co. | 3.51B | 0.68% | 7,239,974 | 6.16B |
| 185 | TNGX | Tango Therapeutics, Inc. | 3.49B | 6.56% | 2,224,330 | 62.38M |
| 186 | NAMS | NewAmsterdam Pharma Company N.V. | 3.43B | -0.03% | 887,387 | 22.50M |
| 187 | OPCH | Option Care Health, Inc. | 3.34B | 0.76% | 6,409,442 | 5.67B |
| 188 | BKD | Brookdale Senior Living Inc. | 3.34B | 0.07% | 1,753,464 | 3.05B |
| 189 | ALMS | Alumis Inc. | 3.32B | 3.49% | 997,303 | 24.05M |
| 190 | MMED | MiniMed Group, Inc. | 3.28B | -1.60% | 452,576 | 2.99B |
| 191 | TMDX | TransMedics Group, Inc. | 3.28B | -2.21% | 2,241,818 | 635.89M |
| 192 | RCUS | Arcus Biosciences, Inc. | 3.27B | 0.04% | 1,150,853 | 236.00M |
| 193 | LIVN | LivaNova PLC | 3.15B | -2.51% | 1,540,638 | 1.39B |
| 194 | KLRA | Kailera Therapeutics, Inc. | 3.14B | -3.31% | 425,204 | - |
| 195 | ERAS | Erasca, Inc. | 3.10B | -1.48% | 4,441,951 | - |
| 196 | PRVA | Privia Health Group, Inc. | 3.05B | 0.21% | 980,019 | 2.12B |
| 197 | DNLI | Denali Therapeutics Inc. | 3.00B | 1.34% | 2,535,662 | - |
| 198 | CON | Concentra Group Holdings Parent, Inc. | 2.93B | 0.66% | 571,707 | 2.16B |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 2.93B | -0.30% | 850,256 | 376.07M |
| 200 | ICUI | ICU Medical, Inc. | 2.92B | -1.40% | 203,299 | 2.23B |
| 201 | GPCR | Structure Therapeutics Inc. | 2.92B | -4.51% | 765,245 | - |
| 202 | ITGR | Integer Holdings Corporation | 2.92B | 2.26% | 681,934 | 1.86B |
| 203 | BEAM | Beam Therapeutics Inc. | 2.90B | -3.92% | 2,053,657 | 139.74M |
| 204 | DYN | Dyne Therapeutics, Inc. | 2.89B | -1.36% | 1,048,873 | - |
| 205 | LFST | LifeStance Health Group, Inc. | 2.85B | 0.96% | 3,308,517 | 1.42B |
| 206 | NKTR | Nektar Therapeutics | 2.84B | -3.14% | 799,170 | 55.23M |
| 207 | TXG | 10x Genomics, Inc. | 2.84B | 1.66% | 3,062,763 | 642.82M |
| 208 | SUPN | Supernus Pharmaceuticals, Inc. | 2.83B | 1.15% | 1,121,313 | 776.83M |
| 209 | TARS | Tarsus Pharmaceuticals, Inc. | 2.77B | 0.73% | 343,312 | 451.36M |
| 210 | SLNO | Soleno Therapeutics, Inc. | 2.74B | 0.04% | 1,472,257 | 190.41M |
| 211 | CLDX | Celldex Therapeutics, Inc. | 2.66B | 3.33% | 725,602 | 1.55M |
| 212 | WRBY | Warby Parker Inc. | 2.65B | -1.50% | 2,347,590 | 871.91M |
| 213 | KOD | Kodiak Sciences Inc. | 2.65B | 0.95% | 973,029 | - |
| 214 | PBH | Prestige Consumer Healthcare Inc. | 2.64B | 0.80% | 550,089 | 1.10B |
| 215 | VCYT | Veracyte, Inc. | 2.63B | -1.43% | 1,494,382 | 541.74M |
| 216 | IMNM | Immunome, Inc. | 2.62B | -0.94% | 638,956 | 6.94M |
| 217 | NHC | National HealthCare Corporation | 2.61B | -2.09% | 65,412 | 1.52B |
| 218 | HAE | Haemonetics Corporation | 2.58B | 0.54% | 753,792 | 1.32B |
| 219 | HTFL | HeartFlow, Inc. | 2.58B | 3.49% | 1,227,008 | 176.03M |
| 220 | IRON | Disc Medicine, Inc. | 2.58B | -0.07% | 322,414 | - |
| 221 | LMAT | LeMaitre Vascular, Inc. | 2.56B | 0.42% | 225,487 | 256.28M |
| 222 | ELVN | Enliven Therapeutics, Inc. | 2.53B | -0.07% | 448,283 | - |
| 223 | IDYA | IDEAYA Biosciences, Inc. | 2.53B | -0.35% | 646,367 | 225.27M |
| 224 | VERA | Vera Therapeutics, Inc. | 2.48B | -2.79% | 1,315,547 | - |
| 225 | RLAY | Relay Therapeutics, Inc. | 2.46B | -0.69% | 1,951,285 | 15.36M |
| 226 | RARE | Ultragenyx Pharmaceutical Inc. | 2.45B | 0.81% | 1,481,952 | 670.00M |
| 227 | DFTX | Definium Therapeutics, Inc. | 2.44B | 2.99% | 1,042,611 | - |
| 228 | MLYS | Mineralys Therapeutics, Inc. | 2.41B | -1.25% | 826,710 | - |
| 229 | ADMA | ADMA Biologics, Inc. | 2.38B | -0.58% | 6,503,833 | 510.17M |
| 230 | GRDN | Guardian Pharmacy Services, Inc. | 2.36B | 1.64% | 301,221 | 1.45B |
| 231 | ZLAB | Zai Lab Limited | 2.36B | -1.13% | 228,260 | 460.16M |
| 232 | AXGN | Axogen, Inc. | 2.33B | 2.60% | 739,344 | 238.11M |
| 233 | ACHC | Acadia Healthcare Company, Inc. | 2.32B | -8.74% | 3,323,278 | 3.37B |
| 234 | SRPT | Sarepta Therapeutics, Inc. | 2.30B | -1.13% | 2,191,319 | 2.20B |
| 235 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.29B | -1.85% | 3,745,178 | 874.84M |
| 236 | HCM | HUTCHMED (China) Limited | 2.29B | 0.61% | 17,245 | 548.51M |
| 237 | PAHC | Phibro Animal Health Corporation | 2.28B | 2.85% | 185,402 | 1.46B |
| 238 | XRAY | DENTSPLY SIRONA Inc. | 2.28B | 1.52% | 9,476,129 | 3.68B |
| 239 | GRAL | GRAIL, Inc. | 2.23B | -2.26% | 720,843 | 156.12M |
| 240 | ADPT | Adaptive Biotechnologies Corporation | 2.20B | -4.97% | 3,187,718 | 295.41M |
| 241 | OCUL | Ocular Therapeutix, Inc. | 2.11B | -0.61% | 4,217,484 | 52.04M |
| 242 | BHC | Bausch Health Companies Inc. | 2.11B | 1.99% | 1,290,594 | 10.53B |
| 243 | ESTA | Establishment Labs Holdings Inc. | 2.09B | 1.07% | 813,786 | 211.08M |
| 244 | AUPH | Aurinia Pharmaceuticals Inc. | 2.08B | 1.71% | 928,880 | 283.06M |
| 245 | TRVI | Trevi Therapeutics, Inc. | 2.06B | 1.95% | 1,020,412 | - |
| 246 | STOK | Stoke Therapeutics, Inc. | 2.05B | -3.57% | 337,473 | 184.42M |
| 247 | SEM | Select Medical Holdings Corporation | 2.04B | - | 765,649 | 5.52B |
| 248 | MESO | Mesoblast Limited | 2.03B | -1.31% | 83,861 | 65.38M |
| 249 | TYRA | Tyra Biosciences, Inc. | 2.02B | -3.44% | 503,511 | - |
| 250 | NEOG | Neogen Corporation | 2.02B | 1.98% | 1,372,715 | 870.56M |
| 251 | AAPG | Ascentage Pharma Group International | 2.01B | -0.54% | 537 | 82.08M |
| 252 | TSHA | Taysha Gene Therapies, Inc. | 1.99B | 4.52% | 2,248,675 | 9.77M |
| 253 | ANAB | AnaptysBio, Inc. | 1.99B | -0.72% | 472,613 | 234.60M |
| 254 | OMCL | Omnicell, Inc. | 1.98B | 0.28% | 540,476 | 1.23B |
| 255 | ZYME | Zymeworks Inc. | 1.97B | -0.37% | 412,700 | 105.97M |
| 256 | GENB | Generate Biomedicines, Inc. | 1.97B | 6.64% | 289,728 | 31.89M |
| 257 | PHVS | Pharvaris N.V. | 1.96B | - | 547,116 | - |
| 258 | VRDN | Viridian Therapeutics, Inc. | 1.93B | 33.36% | 16,131,409 | 70.92M |
| 259 | ANIP | ANI Pharmaceuticals, Inc. | 1.93B | 2.81% | 340,720 | 883.37M |
| 260 | CAPR | Capricor Therapeutics, Inc. | 1.91B | -1.61% | 692,938 | 11.13M |
| 261 | AHG | Akso Health Group | 1.88B | 2.80% | 173,907 | 14.84M |
| 262 | GLPG | Galapagos NV | 1.88B | -0.25% | 75,950 | 1.31B |
| 263 | VCEL | Vericel Corporation | 1.87B | 0.88% | 482,359 | 276.26M |
| 264 | INBX | Inhibrx Biosciences, Inc. | 1.87B | 0.13% | 422,251 | 1.30M |
| 265 | HRMY | Harmony Biosciences Holdings, Inc. | 1.87B | -0.77% | 593,437 | 868.45M |
| 266 | NTLA | Intellia Therapeutics, Inc. | 1.86B | -4.04% | 4,882,346 | 67.67M |
| 267 | PVLA | Palvella Therapeutics, Inc. | 1.85B | 1.46% | 212,306 | - |
| 268 | SION | Sionna Therapeutics, Inc. | 1.85B | 1.29% | 321,341 | - |
| 269 | SGRY | Surgery Partners, Inc. | 1.85B | 0.42% | 2,963,780 | 3.34B |
| 270 | NVCR | NovoCure Limited | 1.84B | -6.20% | 1,957,138 | 674.41M |
| 271 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.83B | -0.18% | 1,024,222 | -665.00K |
| 272 | ADUS | Addus HomeCare Corporation | 1.80B | -1.68% | 623,985 | 1.45B |
| 273 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 0.70% | 1,601,927 | 217.17M |
| 274 | RXRX | Recursion Pharmaceuticals, Inc. | 1.78B | -4.26% | 13,484,742 | 74.68M |
| 275 | ARDX | Ardelyx, Inc. | 1.76B | -2.33% | 5,857,546 | 427.68M |
| 276 | AORT | Artivion, Inc. | 1.74B | 1.07% | 284,133 | 441.33M |
| 277 | ASTH | Astrana Health, Inc. | 1.74B | 0.60% | 519,193 | 3.18B |
| 278 | SNDA | Sonida Senior Living, Inc. | 1.74B | -0.37% | 487,600 | 336.39M |
| 279 | NRIX | Nurix Therapeutics, Inc. | 1.72B | -1.95% | 1,323,024 | 71.78M |
| 280 | RAPP | Rapport Therapeutics, Inc. | 1.70B | 0.17% | 164,335 | - |
| 281 | MD | Pediatrix Medical Group, Inc. | 1.69B | -7.05% | 1,910,829 | 1.93B |
| 282 | NUVB | Nuvation Bio Inc. | 1.68B | 9.52% | 10,891,129 | 143.05M |
| 283 | INVA | Innoviva, Inc. | 1.68B | -1.48% | 620,607 | 411.33M |
| 284 | NBTX | Nanobiotix S.A. | 1.65B | 11.59% | 79,121 | 38.27M |
| 285 | OCS | Oculis Holding AG | 1.64B | -1.80% | 424,669 | 1.51M |
| 286 | IOVA | Iovance Biotherapeutics, Inc. | 1.64B | 3.38% | 18,350,287 | 263.50M |
| 287 | UFPT | UFP Technologies, Inc. | 1.64B | 10.32% | 496,413 | 608.85M |
| 288 | ALMR | Alamar Biosciences, Inc. | 1.63B | 0.59% | 122,657 | 74.21M |
| 289 | AGIO | Agios Pharmaceuticals, Inc. | 1.62B | -1.27% | 870,476 | 66.05M |
| 290 | VIR | Vir Biotechnology, Inc. | 1.61B | -1.67% | 1,038,418 | 68.56M |
| 291 | PRGO | Perrigo Company plc | 1.60B | 2.19% | 2,470,421 | 4.25B |
| 292 | AHCO | AdaptHealth Corp. | 1.60B | -9.89% | 4,741,496 | 3.29B |
| 293 | ATEC | Alphatec Holdings, Inc. | 1.55B | -0.97% | 7,641,973 | 787.08M |
| 294 | GLUE | Monte Rosa Therapeutics, Inc. | 1.55B | -1.12% | 556,921 | 123.67M |
| 295 | PGEN | Precigen, Inc. | 1.53B | 4.59% | 3,866,152 | 9.68M |
| 296 | BCAX | Bicara Therapeutics Inc. | 1.52B | 1.94% | 486,496 | - |
| 297 | HROW | Harrow, Inc. | 1.51B | 0.75% | 442,566 | 272.30M |
| 298 | DMRA | Damora Therapeutics, Inc. | 1.50B | -4.09% | 142,531 | - |
| 299 | HCSG | Healthcare Services Group, Inc. | 1.49B | 2.94% | 552,040 | 1.85B |
| 300 | ATRC | AtriCure, Inc. | 1.49B | 2.12% | 1,466,414 | 534.53M |
| 301 | PGNY | Progyny, Inc. | 1.49B | 0.37% | 1,304,774 | 1.29B |
| 302 | MAZE | Maze Therapeutics, Inc. | 1.47B | -1.37% | 557,418 | 2.50M |
| 303 | IMTX | Immatics N.V. | 1.47B | -1.71% | 640,151 | 56.67M |
| 304 | ATAI | AtaiBeckley Inc. | 1.47B | -4.76% | 4,569,626 | 4.09M |
| 305 | IMCR | Immunocore Holdings plc | 1.47B | 1.12% | 253,007 | 400.02M |
| 306 | BHVN | Biohaven Ltd. | 1.46B | -4.24% | 3,939,594 | - |
| 307 | ARDT | Ardent Health, Inc. | 1.45B | 1.50% | 492,301 | 6.43B |
| 308 | PRCT | PROCEPT BioRobotics Corporation | 1.43B | 1.41% | 893,997 | 322.02M |
| 309 | ABCL | AbCellera Biologics Inc. | 1.41B | 1.53% | 13,351,767 | 75.13M |
| 310 | MBX | MBX Biosciences, Inc. | 1.41B | 0.54% | 312,730 | - |
| 311 | AVAH | Aveanna Healthcare Holdings Inc. | 1.41B | -2.41% | 1,086,594 | 2.43B |
| 312 | INSP | Inspire Medical Systems, Inc. | 1.39B | -12.02% | 4,552,793 | 915.25M |
| 313 | ENOV | Enovis Corporation | 1.39B | 3.34% | 1,028,660 | 2.25B |
| 314 | WVE | Wave Life Sciences Ltd. | 1.38B | -3.88% | 3,222,025 | 71.80M |
| 315 | FTRE | Fortrea Holdings Inc. | 1.37B | 18.61% | 4,228,475 | 2.71B |
| 316 | CLOV | Clover Health Investments, Corp. | 1.37B | -1.51% | 4,201,822 | 1.92B |
| 317 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | 0.19% | 5,317,356 | 73.62M |
| 318 | STAA | STAAR Surgical Company | 1.36B | 0.59% | 855,111 | 239.44M |
| 319 | QURE | uniQure N.V. | 1.33B | 2.32% | 1,566,267 | 18.09M |
| 320 | NVAX | Novavax, Inc. | 1.33B | 0.87% | 3,629,481 | 1.12B |
| 321 | SVRA | Savara Inc. | 1.33B | -0.94% | 927,385 | - |
| 322 | TNDM | Tandem Diabetes Care, Inc. | 1.33B | -2.26% | 1,624,629 | 1.01B |
| 323 | CRVS | Corvus Pharmaceuticals, Inc. | 1.32B | -2.00% | 773,648 | - |
| 324 | GHRS | GH Research PLC | 1.32B | -1.89% | 135,308 | - |
| 325 | AVBP | ArriVent BioPharma, Inc. | 1.32B | -1.81% | 336,468 | - |
| 326 | NNNN | Anbio Biotechnology | 1.28B | -2.60% | 30,263 | 8.65M |
| 327 | OLMA | Olema Pharmaceuticals, Inc. | 1.28B | 0.07% | 673,515 | - |
| 328 | PLSE | Pulse Biosciences, Inc. | 1.27B | -6.89% | 366,438 | 751.00K |
| 329 | MPLT | MapLight Therapeutics, Inc. | 1.27B | -2.41% | 212,357 | - |
| 330 | BFLY | Butterfly Network, Inc. | 1.26B | -0.62% | 5,059,901 | 102.92M |
| 331 | CMPS | COMPASS Pathways plc | 1.26B | -2.10% | 2,661,662 | - |
| 332 | JBIO | Jade Biosciences, Inc. | 1.25B | 3.02% | 295,587 | - |
| 333 | ZBIO | Zenas BioPharma, Inc. | 1.23B | -3.71% | 398,761 | 10.00M |
| 334 | MLTX | MoonLake Immunotherapeutics | 1.22B | -3.13% | 701,352 | - |
| 335 | TDOC | Teladoc Health, Inc. | 1.20B | 0.45% | 6,089,019 | 2.51B |
| 336 | DBVT | DBV Technologies S.A. | 1.19B | 0.10% | 249,104 | 5.74M |
| 337 | KMTS | Kestra Medical Technologies, Ltd. | 1.18B | -1.46% | 203,517 | 83.72M |
| 338 | URGN | UroGen Pharma Ltd. | 1.16B | 2.32% | 759,374 | 109.79M |
| 339 | PHAR | Pharming Group N.V. | 1.16B | -1.34% | 2,171 | 376.13M |
| 340 | NEO | NeoGenomics, Inc. | 1.15B | -1.56% | 1,516,467 | 745.97M |
| 341 | AVNS | Avanos Medical, Inc. | 1.15B | 0.16% | 1,139,107 | 715.90M |
| 342 | EYPT | EyePoint, Inc. | 1.15B | -0.72% | 727,383 | 31.37M |
| 343 | AVLN | Avalyn Pharma Inc. | 1.15B | -5.64% | 467,970 | - |
| 344 | COLL | Collegium Pharmaceutical, Inc. | 1.14B | 2.14% | 390,481 | 780.57M |
| 345 | IVA | Inventiva S.A. | 1.14B | 2.85% | 261,851 | 7.94M |
| 346 | AZTA | Azenta, Inc. | 1.13B | 1.15% | 1,849,168 | 596.48M |
| 347 | EVO | Evotec SE | 1.11B | 2.56% | 32,161 | 925.65M |
| 348 | COAG | Hemab Therapeutics Holdings, Inc. | 1.10B | -1.34% | 461,167 | - |
| 349 | CNMD | CONMED Corporation | 1.10B | 2.12% | 466,999 | 1.37B |
| 350 | PNTG | The Pennant Group, Inc. | 1.10B | 1.16% | 168,721 | 947.71M |
| 351 | IRMD | IRADIMED CORPORATION | 1.10B | 1.11% | 115,958 | 86.28M |
| 352 | ALVO | Alvotech | 1.10B | -0.57% | 208,437 | 588.90M |
| 353 | USPH | U.S. Physical Therapy, Inc. | 1.08B | 1.16% | 164,450 | 773.34M |
| 354 | SEPN | Septerna, Inc. | 1.08B | -2.78% | 298,691 | 45.95M |
| 355 | INNV | InnovAge Holding Corp. | 1.08B | -2.57% | 274,539 | 949.17M |
| 356 | XERS | Xeris Biopharma Holdings, Inc. | 1.08B | -1.74% | 1,418,730 | 291.85M |
| 357 | AKTS | Aktis Oncology, Inc. | 1.07B | 2.32% | 151,401 | 6.50M |
| 358 | CDNA | CareDx, Inc. | 1.07B | -1.24% | 450,672 | 412.82M |
| 359 | OMER | Omeros Corporation | 1.06B | -0.94% | 779,082 | - |
| 360 | GERN | Geron Corporation | 1.06B | 5.10% | 15,760,555 | 183.88M |
| 361 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.04B | 2.86% | 366,945 | 719.89M |
| 362 | BLFS | BioLife Solutions, Inc. | 1.04B | 2.18% | 296,278 | 96.21M |
| 363 | IART | Integra LifeSciences Holdings Corporation | 1.03B | 24.13% | 3,219,893 | 1.64B |
| 364 | WGS | GeneDx Holdings Corp. | 1.02B | -49.20% | 11,259,727 | 442.68M |
| 365 | PHAT | Phathom Pharmaceuticals, Inc. | 1.00B | -2.14% | 1,092,899 | 204.89M |
| 366 | CRON | Cronos Group Inc. | 994.95M | -0.75% | 1,073,874 | 146.59M |
| 367 | MRVI | Maravai LifeSciences Holdings, Inc. | 993.99M | 1.58% | 1,134,213 | 185.74M |
| 368 | ORIC | ORIC Pharmaceuticals, Inc. | 990.66M | -0.62% | 2,027,500 | - |
| 369 | PCRX | Pacira BioSciences, Inc. | 975.44M | 0.41% | 761,643 | 734.86M |
| 370 | SANA | Sana Biotechnology, Inc. | 968.47M | 2.35% | 1,670,038 | - |
| 371 | XNCR | Xencor, Inc. | 952.54M | -3.82% | 697,431 | 125.58M |
| 372 | SDGR | Schrödinger, Inc. | 950.13M | -0.23% | 1,531,069 | 254.91M |
| 373 | CERT | Certara, Inc. | 947.55M | -0.16% | 1,709,335 | 418.84M |
| 374 | LBRX | LB Pharmaceuticals Inc | 942.85M | 3.30% | 125,879 | - |
| 375 | LMRI | Lumexa Imaging Holdings, Inc. | 935.15M | -4.51% | 689,034 | 1.02B |
| 376 | OMDA | Omada Health, Inc. | 929.85M | -0.45% | 964,695 | 260.21M |
| 377 | ANNX | Annexon, Inc. | 929.54M | 0.53% | 1,917,644 | - |
| 378 | CGEM | Cullinan Therapeutics, Inc. | 918.08M | -2.61% | 893,291 | - |
| 379 | INMD | InMode Ltd. | 912.37M | 0.63% | 581,140 | 370.50M |
| 380 | MGTX | MeiraGTx Holdings plc | 902.43M | 0.52% | 480,409 | 81.39M |
| 381 | SLS | SELLAS Life Sciences Group, Inc. | 898.67M | -2.99% | 2,859,379 | - |
| 382 | SPRY | ARS Pharmaceuticals, Inc. | 896.65M | 2.27% | 1,528,441 | 84.28M |
| 383 | ANRO | Alto Neuroscience, Inc. | 892.09M | 1.03% | 292,945 | - |
| 384 | BVS | Bioventus Inc. | 890.98M | 5.01% | 508,820 | 568.09M |
| 385 | CTMX | CytomX Therapeutics, Inc. | 888.19M | -2.39% | 2,395,596 | 76.20M |
| 386 | MNKD | MannKind Corporation | 883.16M | 1.78% | 3,029,569 | 348.97M |
| 387 | GDRX | GoodRx Holdings, Inc. | 876.99M | 2.40% | 1,829,307 | 796.85M |
| 388 | ABSI | Absci Corporation | 872.06M | -0.18% | 5,699,254 | 2.80M |
| 389 | JANX | Janux Therapeutics, Inc. | 871.72M | -0.62% | 1,226,488 | 10.00M |
| 390 | EVMN | Evommune, Inc. | 870.20M | 2.24% | 801,463 | 13.00M |
| 391 | TALK | Talkspace, Inc. | 868.80M | - | 3,033,590 | 228.87M |
| 392 | ABUS | Arbutus Biopharma Corporation | 866.53M | 0.23% | 499,350 | 14.08M |
| 393 | TBPH | Theravance Biopharma, Inc. | 861.48M | -1.06% | 263,399 | 107.46M |
| 394 | OPK | OPKO Health, Inc. | 853.25M | 1.80% | 1,757,722 | 581.12M |
| 395 | SPTX | Seaport Therapeutics, Inc. | 848.45M | -5.88% | 892,723 | - |
| 396 | VOR | Vor Biopharma Inc. | 840.96M | 5.51% | 678,065 | - |
| 397 | DSGN | Design Therapeutics, Inc. | 837.55M | 1.82% | 677,233 | - |
| 398 | NUTX | Nutex Health Inc. | 832.64M | -17.78% | 272,229 | 879.95M |
| 399 | ETON | Eton Pharmaceuticals, Inc. | 831.19M | 0.73% | 572,514 | 79.95M |
| 400 | DRUG | Bright Minds Biosciences Inc. | 827.43M | 3.56% | 178,607 | - |
| 401 | KURA | Kura Oncology, Inc. | 824.61M | 0.43% | 816,875 | 67.48M |
| 402 | AMN | AMN Healthcare Services, Inc. | 822.60M | 2.70% | 879,734 | 2.73B |
| 403 | SGP | SpyGlass Pharma, Inc. | 815.94M | - | 63,862 | - |
| 404 | ESPR | Esperion Therapeutics, Inc. | 803.10M | - | 25,973,872 | 403.14M |
| 405 | QDEL | QuidelOrtho Corporation | 793.99M | -6.12% | 3,186,967 | 2.66B |
| 406 | SSII | SS Innovations International, Inc. | 779.77M | -3.70% | 38,657 | 42.48M |
| 407 | CBLL | CeriBell, Inc. | 771.46M | 0.49% | 319,026 | 89.06M |
| 408 | RLMD | Relmada Therapeutics, Inc. | 770.93M | -0.81% | 719,372 | - |
| 409 | IRWD | Ironwood Pharmaceuticals, Inc. | 761.48M | 1.74% | 4,452,789 | 296.15M |
| 410 | GYRE | Gyre Therapeutics, Inc. | 754.61M | -1.77% | 61,028 | 116.59M |
| 411 | ALLO | Allogene Therapeutics, Inc. | 746.43M | -3.98% | 5,831,796 | 22.00K |
| 412 | CSTL | Castle Biosciences, Inc. | 745.28M | -3.61% | 398,859 | 344.23M |
| 413 | BIOA | BioAge Labs, Inc. | 740.56M | 0.36% | 235,557 | 9.00M |
| 414 | TRAX | First Tracks Biotherapeutics, Inc. | 736.33M | 3.11% | 342,599 | - |
| 415 | TENX | Tenax Therapeutics, Inc. | 735.39M | -6.23% | 416,819 | - |
| 416 | HSTM | HealthStream, Inc. | 713.88M | 14.64% | 421,508 | 311.78M |
| 417 | LXRX | Lexicon Pharmaceuticals, Inc. | 699.07M | 3.12% | 1,588,386 | 49.80M |
| 418 | EHAB | Enhabit, Inc. | 696.94M | - | 407,583 | 1.06B |
| 419 | SLDB | Solid Biosciences Inc. | 679.05M | -4.56% | 1,422,227 | - |
| 420 | TLRY | Tilray Brands, Inc. | 678.72M | -3.56% | 6,266,300 | 858.28M |
| 421 | ARVN | Arvinas, Inc. | 678.63M | -1.58% | 722,403 | 262.60M |
| 422 | CABA | Cabaletta Bio, Inc. | 676.66M | 8.36% | 9,273,168 | - |
| 423 | FBRX | Forte Biosciences, Inc. | 668.01M | -4.28% | 151,609 | - |
| 424 | ACRS | Aclaris Therapeutics, Inc. | 663.40M | 4.86% | 1,072,514 | 7.83M |
| 425 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 661.87M | -2.25% | 173,573 | - |
| 426 | BWAY | BrainsWay Ltd. | 656.42M | - | 88,076 | 52.23M |
| 427 | DRTS | Alpha Tau Medical Ltd. | 650.39M | -1.86% | 759,966 | - |
| 428 | ZVRA | Zevra Therapeutics, Inc. | 627.21M | 5.57% | 989,259 | 106.47M |
| 429 | STRO | Sutro Biopharma, Inc. | 618.31M | -2.79% | 236,771 | 102.48M |
| 430 | AGMB | AgomAb Therapeutics NV | 615.60M | 3.22% | 100,647 | - |
| 431 | CTKB | Cytek Biosciences, Inc. | 614.47M | 2.58% | 793,359 | 201.49M |
| 432 | CRMD | CorMedix Inc. | 606.25M | -2.15% | 850,281 | 311.71M |
| 433 | PRTA | Prothena Corporation plc | 602.39M | 3.71% | 306,816 | 9.68M |
| 434 | CBIO | Crescent Biopharma, Inc. | 600.78M | 0.89% | 380,598 | 11.88M |
| 435 | PRME | Prime Medicine, Inc. | 600.52M | -2.31% | 2,686,744 | 4.63M |
| 436 | SIBN | SI-BONE, Inc. | 599.50M | 1.50% | 654,598 | 200.93M |
| 437 | ANL | Adlai Nortye Ltd. | 597.20M | -0.27% | 223,494 | 5.00M |
| 438 | ALT | Altimmune, Inc. | 594.25M | 1.32% | 3,470,414 | 41.00K |
| 439 | PHR | Phreesia, Inc. | 586.36M | -0.21% | 960,386 | 480.59M |
| 440 | AVR | Anteris Technologies Global Corp. | 583.14M | 0.98% | 413,226 | 1.91M |
| 441 | PSNL | Personalis, Inc. | 582.01M | -5.76% | 2,217,166 | 69.65M |
| 442 | PROK | ProKidney Corp. | 579.77M | 2.13% | 478,807 | 893.00K |
| 443 | NPCE | NeuroPace, Inc. | 578.52M | 0.83% | 116,052 | 99.99M |
| 444 | TRDA | Entrada Therapeutics, Inc. | 575.45M | -0.25% | 402,116 | 25.42M |
| 445 | AURA | Aura Biosciences, Inc. | 571.38M | 6.59% | 5,880,829 | - |
| 446 | DNA | Ginkgo Bioworks Holdings, Inc. | 565.19M | -2.02% | 1,414,474 | 170.16M |
| 447 | CADL | Candel Therapeutics, Inc. | 561.80M | 1.86% | 2,706,143 | - |
| 448 | KYTX | Kyverna Therapeutics, Inc. | 557.48M | 2.33% | 749,514 | - |
| 449 | EIKN | Eikon Therapeutics, Inc. | 556.54M | 0.10% | 148,517 | - |
| 450 | TECX | Tectonic Therapeutic, Inc. | 553.39M | -0.98% | 96,718 | - |
| 451 | CLYM | Climb Bio, Inc. | 546.95M | 18.16% | 1,790,163 | - |
| 452 | TCMD | Tactile Systems Technology, Inc. | 542.48M | 7.22% | 975,705 | 343.52M |
| 453 | MDXG | MiMedx Group, Inc. | 542.16M | 0.83% | 1,918,075 | 389.42M |
| 454 | CTNM | Contineum Therapeutics, Inc. | 537.27M | 1.70% | 134,189 | - |
| 455 | ENGN | enGene Therapeutics Inc. | 528.55M | 3.68% | 426,271 | - |
| 456 | VSTM | Verastem, Inc. | 523.54M | 0.17% | 1,077,655 | 30.91M |
| 457 | AQST | Aquestive Therapeutics, Inc. | 519.51M | -0.95% | 991,591 | 44.55M |
| 458 | RIGL | Rigel Pharmaceuticals, Inc. | 519.10M | -4.91% | 467,037 | 299.77M |
| 459 | CERS | Cerus Corporation | 518.96M | -4.78% | 2,611,211 | 216.56M |
| 460 | VALN | Valneva SE | 509.41M | 2.32% | 7,816 | 205.07M |
| 461 | IMMX | Immix Biopharma, Inc. | 506.80M | 0.84% | 901,087 | - |
| 462 | OCGN | Ocugen, Inc. | 504.39M | -19.46% | 29,509,835 | 4.47M |
| 463 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 464 | OFIX | Orthofix Medical Inc. | 502.85M | 3.58% | 849,131 | 825.37M |
| 465 | XOMA | XOMA Royalty Corporation | 496.41M | 1.51% | 196,901 | 52.15M |
| 466 | UPB | Upstream Bio, Inc. | 496.31M | -2.04% | 262,659 | 2.85M |
| 467 | FDMT | 4D Molecular Therapeutics, Inc. | 495.71M | 2.86% | 541,902 | 85.21M |
| 468 | STTK | Shattuck Labs, Inc. | 494.30M | -5.49% | 516,248 | 1.00M |
| 469 | ZURA | Zura Bio Limited | 491.48M | -2.63% | 510,329 | - |
| 470 | PACB | Pacific Biosciences of California, Inc. | 490.57M | 1.94% | 5,805,955 | 160.01M |
| 471 | OVID | Ovid Therapeutics Inc. | 489.70M | -3.41% | 2,260,342 | 7.25M |
| 472 | WEAV | Weave Communications, Inc. | 485.04M | 0.33% | 1,501,909 | 248.72M |
| 473 | VREX | Varex Imaging Corporation | 483.33M | -0.69% | 205,510 | 854.40M |
| 474 | LYEL | Lyell Immunopharma, Inc. | 481.12M | -0.48% | 51,870 | 36.00K |
| 475 | ADCT | ADC Therapeutics SA | 478.24M | 2.17% | 2,158,278 | 79.18M |
| 476 | SGMT | Sagimet Biosciences Inc. | 476.72M | -2.28% | 1,291,239 | - |
| 477 | RGNX | REGENXBIO Inc. | 475.91M | -1.81% | 436,647 | 170.44M |
| 478 | MYGN | Myriad Genetics, Inc. | 475.05M | 1.82% | 1,439,668 | 829.00M |
| 479 | KMDA | Kamada Ltd. | 472.88M | -0.97% | 23,205 | 180.46M |
| 480 | ASMB | Assembly Biosciences, Inc. | 469.63M | 6.22% | 534,656 | 72.30M |
| 481 | PRLD | Prelude Therapeutics Incorporated | 469.58M | -1.48% | 417,576 | 12.14M |
| 482 | FULC | Fulcrum Therapeutics, Inc. | 467.77M | - | 599,304 | 80.00M |
| 483 | EBS | Emergent BioSolutions Inc. | 466.95M | 5.97% | 1,336,893 | 676.80M |
| 484 | ANGO | AngioDynamics, Inc. | 456.84M | -0.18% | 240,504 | 313.73M |
| 485 | NGNE | Neurogene Inc. | 451.92M | 2.55% | 143,304 | 925.00K |
| 486 | AVIR | Atea Pharmaceuticals, Inc. | 448.15M | -1.75% | 217,464 | - |
| 487 | EPRX | Eupraxia Pharmaceuticals Inc. | 446.33M | -2.02% | 193,074 | - |
| 488 | BBNX | Beta Bionics, Inc. | 446.06M | -2.05% | 319,560 | 110.24M |
| 489 | EVH | Evolent Health, Inc. | 445.81M | -2.01% | 2,031,998 | 1.88B |
| 490 | AGL | agilon health, inc. | 445.48M | -0.74% | 217,305 | 5.93B |
| 491 | VNDA | Vanda Pharmaceuticals Inc. | 444.40M | -2.25% | 895,624 | 216.11M |
| 492 | LXEO | Lexeo Therapeutics, Inc. | 441.56M | 2.76% | 416,493 | - |
| 493 | KIDS | OrthoPediatrics Corp. | 437.67M | 7.98% | 260,023 | 243.30M |
| 494 | CTEV | Claritev Corporation | 436.50M | 4.19% | 49,488 | 965.41M |
| 495 | AUTL | Autolus Therapeutics plc | 436.47M | 4.46% | 1,379,488 | 75.39M |
| 496 | AVTX | Avalo Therapeutics, Inc. | 434.38M | 18.00% | 4,660,396 | 59.00K |
| 497 | FLGT | Fulgent Genetics, Inc. | 423.17M | -1.46% | 872,037 | 320.35M |
| 498 | NRC | NRC Health | 422.34M | 2.85% | 132,991 | 138.64M |
| 499 | ENTA | Enanta Pharmaceuticals, Inc. | 420.20M | -0.41% | 271,712 | 66.98M |
| 500 | NMRA | Neumora Therapeutics, Inc. | 420.18M | -0.43% | 701,455 | - |